...
首页> 外文期刊>International journal of gynecological pathology: Official journal of the International Society of Gynecological Pathologists >Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing
【24h】

Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing

机译:卵巢的双侧标志环基质肿瘤:具有下一代测序分析和FOXL2突变测试的病例报告

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Signet-ring stromal tumor (SRST) is a rare benign stromal neoplasm of the ovary with only a handful of cases reported in the literature. To date, all but one reported cases have been unilateral, and the pathogenesis and underlying genetic abnormalities of this entity are not well characterized. Here we report a case of a 70-yr-old woman with bilateral ovarian SRST, clinically presenting with abdominal distention and rectal bleeding, and bilateral ovarian masses on imaging studies. Total hysterectomy and bilateral salpingo-oophorectomy were performed, revealing bilateral solid ovarian tumors with characteristic signet-ring cell morphology. The immunohistochemical profile-positive steroidogenic factor 1, calretinin, and smooth muscle actin, and negative epithelial membrane antigen-supported the diagnosis of SRST. CTNNB1 mutation and abnormal nuclear beta-catenin expression have recently been reported in 2 SRSTs. However, we did not identify any mutations in 54 oncogenes and tumor suppressor genes (including CTNNB1) by next-generation sequencing analysis, and PCR Sanger sequencing did not reveal FOXL2 C134W mutation, suggesting the possibility of heterogenous pathogenesis of these tumors.
机译:标志环基质肿瘤(SRST)是一种稀有的卵巢良良良性的基质肿瘤,只有在文献中报告的少数病例。迄今为止,除了一个报告的病例之外,所有案件都是单方面,而且该实体的发病机制和潜在的遗传异常表现不佳。在这里,我们举报了一个70年代的女性,双侧卵巢SRST,临床上呈现腹胀和直肠出血,以及对成像研究的双侧卵巢群体。进行了总子宫切除术和双侧Salpingo-Oophorectomy,揭示了双侧固体卵巢肿瘤,具有特征签名戒指细胞形态。免疫组织化学曲线阳性穗类菌酸系1,Caltretinin和平滑肌肌动蛋白,以及负上皮膜抗原支持的SRST诊断。最近报告了CTNNB1突变和异常核β-连环蛋白表达在2 SRST中。然而,我们没有通过下一代测序分析识别54个癌肠和肿瘤抑制基因(包括CTNNB1)中的任何突变,并且PCR桑切尔测序没有揭示FoxL2 C134W突变,表明这些肿瘤的异质发病机制的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号